59 related articles for article (PubMed ID: 27068267)
1. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
[TBL] [Abstract][Full Text] [Related]
2. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
Chang LH; Chang TT; Chu CH; Huang CC; Lin LY
Clin Chim Acta; 2024 May; 558():117880. PubMed ID: 38555050
[TBL] [Abstract][Full Text] [Related]
3. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
Martin WP; Tuohy C; Doody A; Jackson S; Canavan RJ; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
Sci Rep; 2020 Sep; 10(1):14852. PubMed ID: 32908199
[TBL] [Abstract][Full Text] [Related]
4. Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes.
MacIsaac RJ; Farag M; Obeyesekere V; Clarke M; Boston R; Ward GM; Jerums G; Ekinci EI
J Diabetes Investig; 2019 Nov; 10(6):1537-1542. PubMed ID: 30989829
[TBL] [Abstract][Full Text] [Related]
5. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function.
Gohda T; Kamei N; Kubota M; Tanaka K; Yamashita Y; Sakuma H; Kishida C; Adachi E; Koshida T; Murakoshi M; Hagiwara S; Funabiki K; Ueda S; Suzuki Y
J Diabetes Investig; 2021 Mar; 12(3):382-389. PubMed ID: 32643269
[TBL] [Abstract][Full Text] [Related]
6. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
[TBL] [Abstract][Full Text] [Related]
7. A cohort study on the correlation between serum uric acid trajectory and the progression of renal function in patients with Type 2 diabetes mellitus.
Pan J; Yang Q; Peng J; Li A; Liu Y; Yi B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):725-732. PubMed ID: 37539575
[TBL] [Abstract][Full Text] [Related]
8. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
Nadkarni GN; Chauhan K; Verghese DA; Parikh CR; Do R; Horowitz CR; Bottinger EP; Coca SG
Kidney Int; 2018 Jun; 93(6):1409-1416. PubMed ID: 29685497
[TBL] [Abstract][Full Text] [Related]
9. CIRCULATING PEPTIDES OF THE TNF SUPERFAMILY AND TNF RECEPTOR SUPERFAMILY IN SUBJECTS WITH TYPE 1 DIABETES: RELATIONSHIPS WITH CLINICAL AND METABOLIC PARAMETERS.
Klimontov V; Mavlianova K; Semenova J; Orlov N
Georgian Med News; 2023; (340-341):243-248. PubMed ID: 37805905
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes.
Kajiwara A; Kita A; Saruwatari J; Miyazaki H; Kawata Y; Morita K; Oniki K; Yoshida A; Jinnouchi H; Nakagawa K
J Diabetes Res; 2016; 2016():4626382. PubMed ID: 27247948
[TBL] [Abstract][Full Text] [Related]
11. Circulating TNF receptor levels are associated with estimated glomerular filtration rate even in healthy individuals with normal kidney function.
Gohda T; Murakoshi M; Shibata T; Suzuki Y; Takemura H; Tsuchiya K; Okada T; Wakita M; Horiuchi Y; Tabe Y; Kamei N
Sci Rep; 2024 Mar; 14(1):7245. PubMed ID: 38538662
[TBL] [Abstract][Full Text] [Related]
12. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
Pavkov ME; Nelson RG; Knowler WC; Cheng Y; Krolewski AS; Niewczas MA
Kidney Int; 2015 Apr; 87(4):812-9. PubMed ID: 25272234
[TBL] [Abstract][Full Text] [Related]
13. Levels of soluble TNF receptors (sTNFR1 and sTNFR2) increase with clinical worsening of patients and are related to COVID-19 mortality.
Aciole MR; Gonçales JP; Neves PAF; Soares CRP; de Oliveira MI; de Melo HRL; de Lima Neto RG; Moura LCRV; Araújo PSR; de Lorena VMB
Immunobiology; 2024 Jan; 229(1):152748. PubMed ID: 38128238
[TBL] [Abstract][Full Text] [Related]
14. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension.
Yokoyama H; Kanno S; Takahashi S; Yamada D; Itoh H; Saito K; Sone H; Haneda M
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1432-40. PubMed ID: 19713288
[TBL] [Abstract][Full Text] [Related]
15. Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
Basu S; Sussman JB; Berkowitz SA; Hayward RA; Bertoni AG; Correa A; Mwasongwe S; Yudkin JS
Diabetes Care; 2018 Mar; 41(3):586-595. PubMed ID: 29269511
[TBL] [Abstract][Full Text] [Related]
16. Decreased microcirculatory function measured by perfusion index is a novel indicator of diabetic kidney disease in patients with type 2 diabetes.
Okada H; Tanaka M; Yasuda T; Okada Y; Norikae H; Fujita T; Nishi T; Oyamada H; Yamane T; Fukui M
J Diabetes Investig; 2020 May; 11(3):681-687. PubMed ID: 31778299
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor necrosis factor-related biomarkers predict kidney function decline in Japanese patients with diabetes: An observational cohort study.
Murakoshi M; Kamei N; Suzuki Y; Kubota M; Sanuki M; Tashiro H; Iwasawa T; Kato K; Tanaka M; Furuhashi M; Gohda T
Diabetes Res Clin Pract; 2023 Dec; 206():111017. PubMed ID: 37972856
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Plasma Biomarkers to Predict Major Adverse Kidney Events in Hospitalized Patients With COVID-19.
Menez S; Coca SG; Moledina DG; Wen Y; Chan L; Thiessen-Philbrook H; Obeid W; Garibaldi BT; Azeloglu EU; Ugwuowo U; Sperati CJ; Arend LJ; Rosenberg AZ; Kaushal M; Jain S; Wilson FP; Parikh CR;
Am J Kidney Dis; 2023 Sep; 82(3):322-332.e1. PubMed ID: 37263570
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of amphiregulin in patients with chronic kidney disease.
Osakabe Y; Taniguchi Y; Hamada Ode K; Shimamura Y; Inotani S; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Terada Y
Clin Exp Nephrol; 2024 May; 28(5):421-430. PubMed ID: 38402497
[TBL] [Abstract][Full Text] [Related]
20. Commentary on Intraglumerular dysfunction predicts kidney failure in the type 2 diabetes.
Wada J
J Diabetes Investig; 2021 Dec; 12(12):2124-2125. PubMed ID: 34469624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
